Evidence map›Paper›PMID 33206635›Full record

ArticlePLoS genetics2020

Stability of SARS-CoV-2 phylogenies.

Yatish Turakhia, Nicola De Maio, Bryan Thornlow, Landen Gozashti, Robert Lanfear, Conor R Walker, Angie S Hinrichs, Jason D Fernandes, Rui Borges, Greg Slodkowicz and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
2.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Biological causes and impacts of rugged tree landscapes in phylodynamic inference.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Review
  9. Article
  10. A Pandemic-Scale Ancestral Recombination Graph for SARS-CoV-2.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Highly Recurrent Multinucleotide Mutations in SARS-CoV-2.Molecular biology and evolution · 2025
    Article
  13. Article
  14. UShER-TB: Scalable, Comprehensive, Accessible Phylogenomic Analysis ofmedRxiv : the preprint server for health sciences · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Yatish TurakhiaDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA, United States of America.ORCID 0000-0001-5600-2900
Nicola De MaioEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, United Kingdom.ORCID 0000-0002-1776-8564
Bryan ThornlowDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA, United States of America.ORCID 0000-0001-6334-5186
Landen GozashtiDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA, United States of America.
Robert LanfearDepartment of Ecology and Evolution, Research School of Biology, Australian National University, Canberra, ACT, Australia.
Conor R WalkerEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, United Kingdom.ORCID 0000-0001-5617-5086
Angie S HinrichsGenomics Institute, University of California Santa Cruz, Santa Cruz, CA, United States of America.ORCID 0000-0002-1697-1130
Jason D FernandesDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA, United States of America.ORCID 0000-0002-8625-1796
Rui BorgesInstitut für Populationsgenetik, Vetmeduni Vienna, Wien, Austria.ORCID 0000-0002-5905-3778
Greg SlodkowiczMRC Laboratory of Molecular Biology, Cambridge, United Kingdom.ORCID 0000-0001-6918-0386
Lukas WeilgunyEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, United Kingdom.ORCID 0000-0001-6459-0431
David HausslerDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA, United States of America.ORCID 0000-0003-1533-4575
Nick GoldmanEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, United Kingdom.
Russell Corbett-DetigDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA, United States of America.ORCID 0000-0001-6535-2478
European Bioinformatics Institute · GBUniversity of California, Santa Cruz · USHoward Hughes Medical Institute · USAustralian National University · AUHarvard University · USMRC Laboratory of Molecular Biology · GB

Funding

The UCSC Genome BrowserU41HG002371 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI KENT, WILLIAM JAMES · 2012 to 2021
$36.6M
Origins, Functional, and Evolutionary Consequences of Genomic VariationR35GM128932 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Russell Corbett-Detig · 2018 to 2026
$3.2M
Evolutionary dynamics of tRNA genesF31HG010584 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI THORNLOW, BRYAN PATRICK · 2019 to 2021
$86k
Medical Research Council MC_U105185859NHGRI NIH HHS F31 HG010584NHGRI NIH HHS U41 HG002371NIGMS NIH HHS R35 GM128932NIH HHS 5U41HG002371-19
6 · The paper itself

Abstract

The SARS-CoV-2 pandemic has led to unprecedented, nearly real-time genetic tracing due to the rapid community sequencing response. Researchers immediately leveraged these data to infer the evolutionary relationships among viral samples and to study key biological questions, including whether host viral genome editing and recombination are features of SARS-CoV-2 evolution. This global sequencing effort is inherently decentralized and must rely on data collected by many labs using a wide variety of molecular and bioinformatic techniques. There is thus a strong possibility that systematic errors associated with lab-or protocol-specific practices affect some sequences in the repositories. We find that some recurrent mutations in reported SARS-CoV-2 genome sequences have been observed predominantly or exclusively by single labs, co-localize with commonly used primer binding sites and are more likely to affect the protein-coding sequences than other similarly recurrent mutations. We show that their inclusion can affect phylogenetic inference on scales relevant to local lineage tracing, and make it appear as though there has been an excess of recurrent mutation or recombination among viral lineages. We suggest how samples can be screened and problematic variants removed, and we plan to regularly inform the scientific community with our updated results as more SARS-CoV-2 genome sequences are shared (https://virological.org/t/issues-with-sars-cov-2-sequencing-data/473 and https://virological.org/t/masking-strategies-for-sars-cov-2-alignments/480). We also develop tools for comparing and visualizing differences among very large phylogenies and we show that consistent clade- and tree-based comparisons can be made between phylogenies produced by different groups. These will facilitate evolutionary inferences and comparisons among phylogenies produced for a wide array of purposes. Building on the SARS-CoV-2 Genome Browser at UCSC, we present a toolkit to compare, analyze and combine SARS-CoV-2 phylogenies, find and remove potential sequencing errors and establish a widely shared, stable clade structure for a more accurate scientific inference and discourse.

Indexed as

PhylogenyAlgorithmsComputational BiologyCOVID-19Evolution, MolecularGenome, ViralHumansRNA, ViralSARS-CoV-2Sequence AlignmentWhole Genome SequencingRNA, Viral

Identifiers

PMID33206635
PMCPMC7721162
OpenAlexW3103754182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.